G Medical Innovations Holdings Ltd
GMVD · NASDAQ
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -12.6% | 3.2% | -11.3% | – |
| Gross Profit | $0 | $0 | $0 | -$0 |
| % Margin | 17.7% | 29.7% | 13.6% | -4% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -854.1% | -178.7% | -171.4% | -226.5% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -315.8% | -294.3% | -258.9% | -280.6% |
| EPS Diluted | 0 | -45.89 | -60.4 | -7 |
| % Growth | 100% | 24% | -762.9% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | $0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |